Frank LaCreta
New York Times(US)Daiichi Sankyo (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Atrial Fibrillation Management and Outcomes, Pharmacogenetics and Drug Metabolism, Pancreatic function and diabetes, Metabolism, Diabetes, and Cancer
Most-Cited Works
- → Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects(2012)358 cited
- → Characterization of Renal Glucose Reabsorption in Response to Dapagliflozin in Healthy Subjects and Subjects With Type 2 Diabetes(2013)282 cited
- → Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factorXa inhibitor, in healthy subjects(2013)280 cited
- → Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies(2010)277 cited
- → Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects(2013)269 cited
- → Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2(2013)267 cited